These effects, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the thought of targeting ACKR3 as a novel solution to modulate the opioid system, which could open new therapeutic avenues for opioid-connected Diseases. Will help to scale back Continual https://emilew581xtp0.eedblog.com/profile